Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Nasus Pharma Ltd
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001493152-26-025278 (33 Act) Size: KB |
May-26-2026 | 261021133 |
| SCHEDULE 13G | Document | Acc-no: 0001193125-26-225115 (34 Act) Size: KB | May-15-2026 | 26981918 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001493152-26-018607 ( Act) Size: 0 KB |
Apr-22-2026 | |
| SCHEDULE 13G | Document | Acc-no: 0002073679-26-000045 (34 Act) Size: KB | Apr-07-2026 | 26845696 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001493152-26-014503 ( Act) Size: 0 KB |
Apr-01-2026 | |
| EFFECT | Document | Acc-no: 9999999995-26-001019 (33 Act) Size: KB | Mar-31-2026 | 26824501 |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001493152-26-013399 ( Act) Size: 0 KB |
Mar-27-2026 | |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001493152-26-013388 ( Act) Size: 0 KB |
Mar-27-2026 | |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001493152-26-013389 ( Act) Size: 0 KB |
Mar-27-2026 | |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001493152-26-013387 ( Act) Size: 0 KB |
Mar-27-2026 | |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001493152-26-013383 ( Act) Size: 0 KB |
Mar-27-2026 | |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001493152-26-013384 ( Act) Size: 0 KB |
Mar-27-2026 | |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001493152-26-013386 ( Act) Size: 0 KB |
Mar-27-2026 | |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001493152-26-013385 ( Act) Size: 0 KB |
Mar-27-2026 | |
| POS AM | Document | Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001493152-26-013287 (33 Act) Size: KB |
Mar-27-2026 | 26808684 |
| 6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-26-012663 (34 Act) Size: KB |
Mar-25-2026 | 26792429 |
| 20-F | Document | Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001493152-26-012559 (34 Act) Size: KB |
Mar-25-2026 | 26788652 |
| 6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-26-010189 (34 Act) Size: KB |
Mar-16-2026 | 26754523 |
| EFFECT | Document | Acc-no: 9999999995-26-000817 (33 Act) Size: KB | Mar-13-2026 | 26754274 |
| CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001493152-26-009621 ( Act) Size: KB |
Mar-11-2026 |
Recent 20 filings. View all Nasus Pharma Ltd filings
Thanks I look forward to using the product to improve my skin tone
young lad who new his job ansered questions and new what was best for me.
Very good communication and delivery made within the timeframe I was advised of
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by